Faeth Therapeutics, Inc. (FTH) Stock Ticker
Market factors today
Unlock the full FTH picture
About Faeth Therapeutics, Inc.
Faeth Therapeutics, Inc. is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. [28, 70] The company's lead program, PIKTOR, is an investigational all-oral combination therapy targeting the PI3K/AKT/mTOR pathway. [28, 70]
FTH stock facts
| Ticker symbol | FTH |
| Exchange | NASDAQ Capital Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $721.8M |
| CEO | Anand Parikh |
| Employees | 29 |
| Headquarters | Rockville, MD, US |
| IPO date | 2021-02-04 |
| Website | www.faeththerapeutics.com |
What you can see for FTH on Tickr
Live FTH price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the FTH report.
Rankings
FAQ
What is the ticker symbol for Faeth Therapeutics, Inc.?
The ticker symbol for Faeth Therapeutics, Inc. is FTH, listed on the NASDAQ Capital Market.
What is FTH?
Faeth Therapeutics, Inc. is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. [28, 70] The company's lead program, PIKTOR, is an investigational all-oral combination therapy targeting the PI3K/AKT/mTOR pathway. [28, 70]